KINTARA THERAPEUTICS INC (KTRA)

US49720K2006 - Common Stock

0.1739  +0 (+1.76%)

After market: 0.1775 +0 (+2.07%)

News Image
3 days ago - Chartmill

Curious about the stocks that are showing activity after the closing bell on Wednesday?

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

News Image
19 days ago - Kintara Therapeutics

TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer

/PRNewswire/ -- TuHURA Biosciences, Inc. ("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance...

News Image
2 months ago - Kintara Therapeutics

TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor

KVA12123 is a rationally targeted, anti-VISTA antibody checkpoint inhibitor to reverse VISTA immune suppression and remodel the tumor microenvironment (TME) to...

News Image
2 months ago - Kintara Therapeutics

Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutical company focused on the development of new solid tumor cancer...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

News Image
3 months ago - Kintara Therapeutics

TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

/PRNewswire/ -- TuHURA Biosciences, Inc. ("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are a great way to start the trading week and we have all of the hottest news worth reading about on Monday!

News Image
4 months ago - InvestorPlace

KTRA Stock Earnings: Kintara Therapeutics Reported Results for Q3 2024

Kintara Therapeutics just reported results for the third quarter of 2024.

News Image
4 months ago - BusinessInsider

KTRA Stock Earnings: Kintara Therapeutics Reported Results for Q3 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kintara Therapeutics (NASDAQ:KTRA) just reported results for the third quarter ...

News Image
4 months ago - Kintara Therapeutics

Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

News Image
5 months ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, CTLT, SCX, KTRA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
5 months ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, SCX, KTRA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
5 months ago - Kuehn Law, PLLC

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm

/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law...